-
Je něco špatně v tomto záznamu ?
SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer
F. Boria, L. Chiva, E. Chacon, V. Zanagnolo, A. Fagotti, A. Kucukmetin, C. Mom, G. Chakalova, A. Shamistan, M. Malzoni, F. Narducci, O. Arencibia, F. Raspagliesi, T. Toptas, D. Cibula, D. Kaidarova, MM. Meydanli, M. Tavares, D. Golub, AM....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2001-01-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2001-01-01 do Před 6 měsíci
PubMed
36583728
DOI
10.1136/ijgc-2022-003790
Knihovny.cz E-zdroje
- MeSH
- hysterektomie MeSH
- lidé MeSH
- lokální recidiva nádoru chirurgie MeSH
- nádory děložního čípku * patologie MeSH
- retrospektivní studie MeSH
- staging nádorů MeSH
- ukazatele kvality zdravotní péče MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: To evaluate whether compliance with European Society of Gynaecological Oncology (ESGO) surgery quality indicators impacts disease-free survival in patients undergoing radical hysterectomy for cervical cancer. METHODS: In this retrospective cohort study, 15 ESGO quality indicators were assessed in the SUCCOR database (patients who underwent radical hysterectomy for International Federation of Gynecology and Obstetrics (FIGO) stage 2009 IB1, FIGO 2018 IB1, and IB2 cervical cancer between January 2013 and December 2014), and the final score ranged between 0 and 16 points. Centers with more than 13 points were classified as high-quality indicator compliance centers. We constructed a weighted cohort using inverse probability weighting to adjust for the variables. We compared disease-free survival and overall survival using Cox proportional hazards regression analysis in the weighted cohort. RESULTS: A total of 838 patients were included in the study. The mean number of quality indicators compliance in this cohort was 13.6 (SD 1.45). A total of 479 (57.2%) patients were operated on at high compliance centers and 359 (42.8%) patients at low compliance centers. High compliance centers performed more open surgeries (58.4% vs 36.7%, p<0.01). Women who were operated on at centers with high compliance with quality indicators had a significantly lower risk of relapse (HR=0.39; 95% CI 0.25 to 0.61; p<0.001). The association was reduced, but remained significant, after further adjustment for conization, surgical approach, and use of manipulator surgery (HR=0.48; 95% CI 0.30 to 0.75; p=0.001) and adjustment for adjuvant therapy (HR=0.47; 95% CI 0.30 to 0.74; p=0.001). Risk of death from disease was significantly lower in women operated on at centers with high adherence to quality indicators (HR=0.43; 95% CI 0.19 to 0.97; p=0.041). However, the association was not significant after adjustment for conization, surgical approach, use of manipulator surgery, and adjuvant therapy. CONCLUSIONS: Patients with early cervical cancer who underwent radical hysterectomy in centers with high compliance with ESGO quality indicators had a lower risk of recurrence and death.
Agostino Gemelli IRCCS Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
Amsterdam University Medical Centres Amsterdam Noord Holland The Netherlands
Bellvitge University Hospital L'Hospitalet de Llobregat Catalunya Spain
Catholic University of the Sacred Heart Milano Lombardia Italy
Clinic of Obstetrics and Gynecology Hospital San Gerardo Monza Italy
Clinical Hospital Center Rijeka Rijeka Croatia
Department of Gynaecological Oncology Queen Alexandra Hospital Portsmouth NHS Trust Portsmouth UK
Department of Gynecologic Oncology La Fe University and Polytechnic Hospital Valencia Spain
Department of Gynecologic Oncology La Paz University Hospital Madrid Spain
Department of Gynecologic Oncology Universidad de Navarra Pamplona Navarra Spain
Department of Gynecological Oncology Radboudumc Nijmegen Netherlands
Department of Gynecology and Oncology Jagiellonian University Krakow Poland
Department of Gynecology Centre Oscar Lambret Lille France
Department of Gynecology Instituto Português de Oncologia de Lisboa Lisbon Portugal
Department of Gynecology University Maternal Hospital Canary Islands Las Palmas Las Palmas Spain
Department of Medicine and Surgery University of Milan Bicocca Milan Italy
Department of Obstetrics and Gynecology Clinica Universidad de Navarra Madrid Spain
Department of Obstetrics and Gynecology Tampere University Hospital Tampere Finland
Department of Obstetrics and Gynecology Unit of Gynecologic Oncology
Department of Obstetrics and Gynecology University of Liege Liege Belgium
Department of Obstetrics and Gynecology University of Prague Prague Czech Republic
Department of Preventive Medicine and Public Health Universidad de Navarra Pamplona Spain
Department of Surgery Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
Department of Surgery LISOD Israeli Oncological Hospital Kyiv Region Ukraine
Endoscopica Malzoni Center for Advanced Endoscopic Gynecologic Surgery Avellino Italy
Faculty of Medicine University of Debrecen Debrecen Hungary
Hospital Universitario Donostia San Sebastian Spain
Institut Curie Paris Île de France France
Institute of Obstetrics and Gynecology
Istanbul University Cerrrahpasa Medical Faculty istanbul Turkey
Istituto Europeo di Oncologia Milan Italy
Lviv Oncology Center Lviv Ukraine
Metaxa Cancer Hospital of Piraeus Piraeus Attika Greece
National Center of Oncology Baku Azerbaijan
North Estonia Medical Centre Tallinn Estonia
Queen Elizabeth Hospital Gateshead Gateshead UK
University Hospitals of Leicester NHS Trust Leicester Leicester UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004934
- 003
- CZ-PrNML
- 005
- 20230425171816.0
- 007
- ta
- 008
- 230418s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/ijgc-2022-003790 $2 doi
- 035 __
- $a (PubMed)36583728
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Boria, Felix $u Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain $1 https://orcid.org/0000000247616190
- 245 10
- $a SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer / $c F. Boria, L. Chiva, E. Chacon, V. Zanagnolo, A. Fagotti, A. Kucukmetin, C. Mom, G. Chakalova, A. Shamistan, M. Malzoni, F. Narducci, O. Arencibia, F. Raspagliesi, T. Toptas, D. Cibula, D. Kaidarova, MM. Meydanli, M. Tavares, D. Golub, AM. Perrone, R. Poka, PLM. Zusterzeel, I. Aluloski, F. Goffin, D. Haidopoulos, H. Haller, R. Jach, I. Yezhova, M. Bernardino, R. Bharathan, MM. Maenpaa, V. Sukhin, JG. Feron, R. Fruscio, K. Kukk, J. Ponce, F. Demirkiran, G. Vorgias, N. Povolotskaya, PJ. Coronado Martín, T. Marina, I. Zapardiel, N. Bizzarri, M. Gorostidi, M. Gutierrez, N. Manzour, A. Berasaluce, N. Martin-Calvo, SUCCOR study Group
- 520 9_
- $a OBJECTIVE: To evaluate whether compliance with European Society of Gynaecological Oncology (ESGO) surgery quality indicators impacts disease-free survival in patients undergoing radical hysterectomy for cervical cancer. METHODS: In this retrospective cohort study, 15 ESGO quality indicators were assessed in the SUCCOR database (patients who underwent radical hysterectomy for International Federation of Gynecology and Obstetrics (FIGO) stage 2009 IB1, FIGO 2018 IB1, and IB2 cervical cancer between January 2013 and December 2014), and the final score ranged between 0 and 16 points. Centers with more than 13 points were classified as high-quality indicator compliance centers. We constructed a weighted cohort using inverse probability weighting to adjust for the variables. We compared disease-free survival and overall survival using Cox proportional hazards regression analysis in the weighted cohort. RESULTS: A total of 838 patients were included in the study. The mean number of quality indicators compliance in this cohort was 13.6 (SD 1.45). A total of 479 (57.2%) patients were operated on at high compliance centers and 359 (42.8%) patients at low compliance centers. High compliance centers performed more open surgeries (58.4% vs 36.7%, p<0.01). Women who were operated on at centers with high compliance with quality indicators had a significantly lower risk of relapse (HR=0.39; 95% CI 0.25 to 0.61; p<0.001). The association was reduced, but remained significant, after further adjustment for conization, surgical approach, and use of manipulator surgery (HR=0.48; 95% CI 0.30 to 0.75; p=0.001) and adjustment for adjuvant therapy (HR=0.47; 95% CI 0.30 to 0.74; p=0.001). Risk of death from disease was significantly lower in women operated on at centers with high adherence to quality indicators (HR=0.43; 95% CI 0.19 to 0.97; p=0.041). However, the association was not significant after adjustment for conization, surgical approach, use of manipulator surgery, and adjuvant therapy. CONCLUSIONS: Patients with early cervical cancer who underwent radical hysterectomy in centers with high compliance with ESGO quality indicators had a lower risk of recurrence and death.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a nádory děložního čípku $x patologie $7 D002583
- 650 _2
- $a ukazatele kvality zdravotní péče $7 D019984
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a lokální recidiva nádoru $x chirurgie $7 D009364
- 650 _2
- $a hysterektomie $7 D007044
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chiva, Luis $u Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain lchiva@unav.es $1 https://orcid.org/0000000219083251
- 700 1_
- $a Chacon, Enrique $u Department of Gynecologic Oncology, Universidad de Navarra, Pamplona, Navarra, Spain $1 https://orcid.org/0000000186598602
- 700 1_
- $a Zanagnolo, Vanna $u Istituto Europeo di Oncologia, Milan, Italy
- 700 1_
- $a Fagotti, Anna $u Agostino Gemelli IRCCS, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy $u Catholic University of the Sacred Heart, Milano, Lombardia, Italy $1 https://orcid.org/000000015579335X
- 700 1_
- $a Kucukmetin, Ali $u Queen Elizabeth Hospital, Gateshead, Gateshead, UK
- 700 1_
- $a Mom, Constantijne $u Amsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands
- 700 1_
- $a Chakalova, Galina $u University Oncologic Hospital, Sofia, Bulgaria
- 700 1_
- $a Shamistan, Aliyev $u National Center of Oncology, Baku, Azerbaijan
- 700 1_
- $a Malzoni, Mario $u Endoscopica Malzoni, Center for Advanced Endoscopic Gynecologic Surgery, Avellino, Italy
- 700 1_
- $a Narducci, Fabrice $u Department of Gynecology, Centre Oscar Lambret, Lille, France
- 700 1_
- $a Arencibia, Octavio $u Department of Gynecology, University Maternal Hospital Canary Islands, Las Palmas, Las Palmas, Spain
- 700 1_
- $a Raspagliesi, Francesco $u Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- 700 1_
- $a Toptas, Tayfun $u Department of Gynecologic Oncology, Saglik Bilimleri University Antalya Research and Training Hospital, Antalya, Turkey $1 https://orcid.org/0000000267066915
- 700 1_
- $a Cibula, David $u Department of Obstetrics and Gynecology, University of Prague, Prague, Czech Republic
- 700 1_
- $a Kaidarova, Dilyara $u Department of Oncogynecology, Kazahskij naucno-issledovatel'skij institut onkologii i radiologii, Almaty, Kazakhstan
- 700 1_
- $a Meydanli, Mehmet Mutlu $u Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey $1 https://orcid.org/0000000167639720
- 700 1_
- $a Tavares, Mariana $u IPO-PORTO, Porto, Portugal
- 700 1_
- $a Golub, Dmytro $u Department of Surgery, LISOD - Israeli Oncological Hospital, Kyiv Region, Ukraine
- 700 1_
- $a Perrone, Anna Myriam $u Division of Gynecologic Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico S Orsola-Malpighi, Bologna, Italy $1 https://orcid.org/0000000331404772
- 700 1_
- $a Poka, Robert $u Department of Obstetrics and Gynecology, Unit of Gynecologic Oncology; Institute of Obstetrics and Gynecology; Faculty of Medicine, University of Debrecen, Debrecen, Hungary $1 https://orcid.org/0000000318361579
- 700 1_
- $a Zusterzeel, Petra L M $u Department of Gynecological Oncology, Radboudumc, Nijmegen, Netherlands
- 700 1_
- $a Aluloski, Igor $u Department of Gynecologic Oncology, University Clinic of Gynecology and Obstetrics, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopjeskopje, Macedonia
- 700 1_
- $a Goffin, Frederic $u Department of Obstetrics and Gynecology, University of Liege, Liege, Belgium
- 700 1_
- $a Haidopoulos, Dimitrios $u Division of Gynecologic Oncology, 1st Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Haller, Herman $u Clinical Hospital Center Rijeka, Rijeka, Croatia
- 700 1_
- $a Jach, Robert $u Department of Gynecology and Oncology, Jagiellonian University, Krakow, Poland
- 700 1_
- $a Yezhova, Iryna $u Lviv Oncology Center, Lviv, Ukraine
- 700 1_
- $a Bernardino, Margarida $u Department of Gynecology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
- 700 1_
- $a Bharathan, Rasiah $u University Hospitals of Leicester NHS Trust, Leicester, Leicester, UK
- 700 1_
- $a Maenpaa, Minna M $u Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland
- 700 1_
- $a Sukhin, Vladyslav $u Department of Oncology, Radiology and Radiation Medicine, V N Karazin Kharkiv National University, Harkiv, Ukraine $u Department of Oncogynecology, Grigoriev Institute for Medical Radiology NAMS of Ukraine, Harkiv, Ukraine $1 https://orcid.org/0000000244033707
- 700 1_
- $a Feron, Jean-Guillaume $u Institut Curie, Paris, Île-de-France, France
- 700 1_
- $a Fruscio, Robert $u Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy $u Clinic of Obstetrics and Gynecology, Hospital San Gerardo, Monza, Italy $1 https://orcid.org/0000000156882194
- 700 1_
- $a Kukk, Kersti $u North Estonia Medical Centre, Tallinn, Estonia
- 700 1_
- $a Ponce, Jordi $u Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalunya, Spain
- 700 1_
- $a Demirkiran, Fuat $u Istanbul University Cerrrahpasa Medical Faculty, istanbul, Turkey
- 700 1_
- $a Vorgias, George $u Metaxa Cancer Hospital of Piraeus, Piraeus, Attika, Greece
- 700 1_
- $a Povolotskaya, Natalia $u Department of Gynaecological Oncology, Queen Alexandra Hospital, Portsmouth NHS Trust, Portsmouth, UK
- 700 1_
- $a Coronado Martín, Pluvio J $u Department of Obstetrics and Gynecology, Hospital Clinico San Carlos IdISSC, Complutense University, Madrid, Spain
- 700 1_
- $a Marina, Tiermes $u Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, Valencia, Spain $1 https://orcid.org/0000000233075346
- 700 1_
- $a Zapardiel, Ignacio $u Department of Gynecologic Oncology, La Paz University Hospital, Madrid, Spain $1 https://orcid.org/0000000291757767
- 700 1_
- $a Bizzarri, Nicolò $u UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Policlinico Agostino Gemelli IRCCS, Rome, Italy $1 https://orcid.org/000000021727904X
- 700 1_
- $a Gorostidi, Mikel $u Hospital Universitario Donostia, San Sebastian, Spain $1 https://orcid.org/0000000151502797
- 700 1_
- $a Gutierrez, Monica $u Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain
- 700 1_
- $a Manzour, Nabil $u Department of Gynecologic Oncology, Universidad de Navarra, Pamplona, Navarra, Spain $1 https://orcid.org/0000000246046042
- 700 1_
- $a Berasaluce, Arantxa $u Department of Preventive Medicine and Public Health, Clinica Universidad de Navarra, Pamplona, Navarra, Spain
- 700 1_
- $a Martin-Calvo, Nerea $u ,Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain
- 710 2_
- $a SUCCOR study Group
- 773 0_
- $w MED00009896 $t International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 32, č. 10 (2022), s. 1236-1243
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36583728 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171812 $b ABA008
- 999 __
- $a ok $b bmc $g 1925183 $s 1191143
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 32 $c 10 $d 1236-1243 $e 20221003 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
- LZP __
- $a Pubmed-20230418
